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Abstract—Inflammatory bowel disease (IBD) is a group of
inflammatory diseases of the human colon and small intestine.
IBD symptoms are non-specific; diagnosis can be delayed because
an invasive colonoscopy is required for confirmation. Delayed
diagnosis is linked to poor growth in children. Imbalances in the
human intestinal microbiome - the community of microorganisms
that reside in the human gut - are thought to contribute to
the development of IBD. Work done to date in classifying
host health statuses from patterns in human microbiomes with
supervised learning algorithms has focused on modelling what
is present in the gut (i.e. a bacterial census) with the random
forest algorithm. Metagenomic shotgun sequencing is required to
understand what is occurring in the gut (i.e. gene functions) and
is often cost prohibitive for hundreds of samples. However, gene
functions can be predicted with the Phylogenetic Investigation of
Communities by Reconstruction of Unobserved States (PiCRUSt)
software package, which could represent a valuable source of
new features. In this paper we investigate feature relevance
across the feature set with the Boruta algorithm. We find
that the majority of relevant features are from the predicted
metagenome. Support vector machines (SVM) and multilayer
perceptrons (MLP) are rarely used with microbiomic datasets
but offer several theoretical advantages. To determine if the
new features and alternative algorithms are appropriate, we
experiment with a range of machine learning and computational
intelligence algorithms. With the best performing algorithms we
also implement a conditional multiple classifier system that can
identify IBD presence, IBD subtype, and IBD activity from a
non-invasive stool sample.
I. INTRODUCTION
Inflammatory bowel disease (IBD) is a group of disorders
that cause persistent inflammation of the gut. IBD caused
53,000 deaths worldwide in 2013 and its prevalence is in-
creasing [1]. IBD symptomatology is generally nonspecific and
diagnosis is usually confirmed via invasive colonoscopy, with
consequent delays. Delayed paediatric IBD diagnosis reduces
growth significantly and is linked to poor treatment outcomes
[2]. In [3], a bacterial census of the intestinal microbiome,
defined below, was combined with a machine learning ap-
proach in order to classify IBD presence and IBD subtype.
This approach analysed the bacterial groups present in the gut
of IBD and control subjects; measuring what is occurring in
the gut (i.e. abundance of gene functions) could provide a
superior feature set for a supervised learning algorithm.
The human intestinal microbiome consists of the symbiotic,
pathogenic, and commensal organisms that reside in the small
intestine and colon. Investigating the intestinal microbiome
requires microbial DNA to be taken directly from an en-
vironmental sample (i.e. stool in order to study the gut).
This analysis is known as metagenomics. Once a sample
is collected, DNA is isolated and sequenced. Marker gene
surveys can create a bacterial census with traditional Sanger
sequencing. 16S ribosomal RNA (rRNA) is commonly used
as a marker gene when investigating the intestinal microbiome
because it is a cost-effective protocol and only bacteria can be
identified, negating contamination from the host.
Metagenomic shotgun sequencing is required to determine
what is occurring (i.e. gene functions). In shotgun sequenc-
ing DNA molecules are broken into many pieces. These
pieces are sequenced in a highly parallelised manner in a
process known as next generation sequencing. The strands
are then recombined in silico to form a continuous sequence
for downstream analysis. Metagenomic shotgun sequencing
of dozens or hundreds of samples is often cost prohibitive.
An algorithm that can infer gene functions from a bacterial
census via a reference database has been developed, dubbed
Phylogenetic Investigation of Communities by Reconstruction
of Unobserved States (PiCRUSt) [4] and will be used in this
work.
Supervised learning algorithms have been used to identify
host health statuses from marker gene surveys of human mi-
crobiomes for a number of conditions including IBD, irritable
bowel syndrome, and pregnancy [3], [5], [6]. Random forests
have been the sole learning algorithm used to date. Although,
according to the no free lunch theorem [7], there will be no sin-
gle best model for all metagenomic datasets, algorithms such
as support vector machines (SVM) and multilayer perceptrons
(MLP) have found success in DNA microarray analysis but
are rarely applied to metagenomic classification problems. An
extension of the no free lunch theorem holds that multiple
classifier systems are superior to a single “computational point
of view”, and can result in better performance [8].
This paper presents a novel conditional multiple classifier
system (hybrid classifier) that is able to identify IBD presence,
IBD subtype, and IBD activity from a stool sample in a non-
invasive manner with the aim of reducing time to diagnosis and
reducing the need for invasive colonoscopy. To date inferred
metagenomes have not been used as a source of features for
disease classification. Additionally, multiple classifier systems
have not been applied to the classification of IBD previously.
II. BACKGROUND AND RELATED RESEARCH
Industrialised western nations have the highest IBD inci-
dence and prevalence - approximately 261,000 people suffer
from IBD in the United Kingdom - and this has increased
significantly worldwide since the start of the 20th century
[1]. IBD symptoms include abdominal pain, weight loss, and
diarrhoea. In severe cases surgical intervention is required and
the inflamed parts of the gastrointestinal tract are removed.
IBD is a complex disease with uncertain aetiology [9]. IBD
has two major subtypes: Ulcerative colitis - the effects of
which are limited to the gut - and Crohn’s disease, which can
affect the entire gastrointestinal tract. IBD is usually episodic
and severe inflammation is considered to be active IBD. IBD
can enter remission during periods in which limited or no
symptoms occur. IBD diagnosis is slow in children because
IBD has non-specific symptoms; Colonoscopy is a specialised
procedure and IBD symptoms are required before colonoscopy
will be used for confirmation. Thus further development of
non-invasive tests for IBD would be valuable.
A non-invasive test for paediatric IBD has been developed
by mapping the intestinal microbiome [3]. These tests use a
supervised learning approach to identify IBD presence and
IBD subtypes. Mapping the intestinal microbiome to classify
health status has to date been limited to analysing the relative
abundances of bacterial taxonomic groups (i.e. what is present
in the gut). This approach has been the most commonly used
algorithm for classification of health status from patterns in hu-
man microbiomes [3], [5], [6]. An extension of this approach is
to analyse the diversity and abundance of bacteria in a modular
fashion instead of investigating biological species. Bacterial
species in a metagenome can differ significantly between
subjects [10]. A consequence of this is that relevant features or
trained models can suffer from poor generalisation. Random
forests have found widespread use classifying samples into
microbiome phenotypes due to the excellent performance of
the algorithm.
Other valuable algorithms that have been used less fre-
quently in metagenomic classification problems include SVMs
and MLPs. SVM classifiers are robust to a large number of
irrelevant features and high feature-to-sample ratios, and use
regularisation techniques to avoid overfitting [11]. MLPs and
deep learning have only recently been applied to metagenomic
classification, and show good results [12]. Due to the reliance
on subjective diagnostic criteria for diagnosing IBD activity,
learning a model for IBD activity could represent a non-
linear problem: hence different SVM kernels and MLPs were
experimented with. Combining multiple classifier systems into
a hybrid system has not been done to date in the field of
metagenomics.
In summary the literature has focused on classifying host
health statuses from surveys of bacterial groups present in the
intestinal microbiome with the use of random forest ensemble
learning algorithms. A proposed extrapolation of the no free
lunch theorem is that no single computational model solves
all problems, demonstrating the advantage of hybrid models
[8]. The aim of this work is two-fold: i) to determine the
relevance (via the Boruta algorithm) of what is occurring
in the intestinal microbiome of IBD subjects by generating
a predicted metagenome with PiCRUSt; ii) to test a variety
of supervised learning algorithms with the novel PiCRUSt-
derived features and build a hybrid classifier using the best
performing features and algorithms.
III. DATA PREPROCESSING
16S ribosomal DNA was sourced from a publically available
dataset [3]. In this dataset DNA was isolated from faecal
samples of 158 children (control n=37, IBD n=122). The
sequenced DNA was processed to remove poor quality se-
quences, technical artefacts, and chimeric sequences before
being uploaded to the Sequence Read Archive. In this dataset
a sample is defined as all DNA sequences identified by the 16S
marker gene survey per faecal sample. The DNA sequences
identify hundreds of different bacterial groups per sample.
A. Obtaining a vector representation of bacterial presence and
abundance
The DNA sequences were mapped to vector representa-
tions in order to input them into supervised learning classi-
fication algorithms. An Operational Taxonomic Unit (OTU)
approach was used to generate these vector representations
from DNA sequences (see figure 1). Bacterial taxonomic
groups were identified and clustered from the similarity of
the DNA sequences present per sample. DNA sequences that
are 97% similar are commonly binned into the same OTU.
The Quantitative Insights Into Microbial Ecology (QIIME)
software package [13] was used to generate OTU tables (a
community data matrix), with the open-reference subsampled
OTU picking algorithm. The OTU table recorded how many
times an identified OTU occurred for each sample. OTU
abundances were scaled to be in the range [0, 1].
B. Obtaining a vector representation of functional genetic
content
The Phylogenetic Investigation of Communities by Recon-
struction of Unobserved States (PiCRUSt) algorithm [4] was
used to infer functional content from the marker gene survey.
Marker gene surveys only identify specific genes and can only
identify taxonomic and phylogenetic features. Metagenomic
shotgun sequencing is usually required to investigate metabolic
and functional features. Deep metagenomic sequencing of
hundreds of samples remains cost prohibitive. PiCRUSt infers
genetic content from bacterial phylogenies via comparison to
a database of reference genomes. The presence and abundance
of gene functions present per sample were binned into cate-
gories and abundances were scaled to be in the range [0, 1].
C. Obtaining vector representations of subject clinical data
Subject clinical history was converted from categorical
variables to indicator variables (e.g. has the patient been pre-
scribed immunosuppressant drugs). Immunosuppressant drugs
Fig. 1. Feature engineering pipeline. Subject clinical data is converted from categorical variables (e.g. family history of IBD) to artificial indicator variables.
16S ribosomal DNA was sourced from a publically available dataset (NCBI BioProjectID 82109 [3]), and consisted of the stool of 158 children (symptomatic
controls n=37, IBD n=122) Operational Taxonomic Unit (OTU) picking clusters bacteria into groups from the similarity of their DNA. Typically if two DNA
samples are at least 97% similar they can be considered to be in the same OTU.
and antibiotics [14] have been shown to cause large long
term changes to microbiomes across the human body and it
is thus essential to record their application. Other clinical data
includes subject ethnicity and family history of IBD.
IV. FEATURE SELECTION AND FEATURE RELEVANCE
Feature selection was applied in stage III with a MLP
because high dimensional learning with traditional artificial
neural networks is difficult [15]. 3-fold cross-validated SVM
recursive feature elimination (SVM-RFE [16]) was used to
automatically identify the optimal number of features. SVMs
show good performance on high dimensional classification
problems. SVM-RFE repeatedly eliminates the features least
important (measured by SVM feature weights) to classification
performance until the optimum is reached.
Boruta - an all-relevant feature selection algorithm based on
a random forest wrapper and widely used in metagenomics
[17] - was chosen to assess which features were relevant
for each stage of the hybrid classifier (see Table I). By
identifying every relevant feature in a classification problem
the underlying mechanisms can be explored.
V. MULTIPLE CLASSIFIER SYSTEM CLASSIFICATION
Multiple classifier systems (hybrid intelligent systems) have
many advantages: combined classifiers can outperform the
best individual classifiers, multiple classifiers are more likely
to find an optimal model, and multiple classifiers can be
efficiently implemented in a multi-threaded environment in a
parallel manner. The topology of multiple classifier systems
is usually parallel or conditional. In parallel topology each
classifier has identical inputs, and the final decision is made
from the combined outputs of each classifier. In conditional
topology, classifiers are used in a serial manner. Input is only
passed to the classifier next in the sequence if some condition
is met. Hybrid classifiers have found use in highly dimensional
medical data sets including the classification of Alzheimer’s
disease from structural fMRI data. In this paper we used a
serial classifier system. By returning a reduced set of classes
at each stage of the serial classifier a complex problem can be
iteratively decomposed into a series of simpler problems that
are easier to classify.
A. Topology
The topology of the serial multiple classifier system (see
Figure 2) was designed so that a complex problem (thorough
IBD diagnosis) could be reduced to a set of simpler, but
clinically important, problems. The presence of IBD (i.e. IBD
or control) is important to guide treatment options. Some IBD
treatments are contraindicated for subjects with conditions that
can be misdiagnosed as IBD (i.e. prescribing immunosuppres-
sant drugs for amoebic dysentery). The subtype of IBD and
current IBD activity is important to guide the treatment course
(e.g. severe Crohn’s disease may require surgical intervention).
B. Classifier choice
The performance of SVMs and random forests was com-
pared on the first two stages. These algorithms were picked
because random forests have found widespread use in metage-
nomic classification problems, and SVMs have been shown to
be on average superior to random forests on DNA microarray
datasets [18]. DNA microarray data sets share many properties
with metagenomic datasets such as high feature-to-sample
ratios and large feature counts. SVMs were found to have
superior performance to random forests for the first two stages.
The last class (IBD activity) is based on a subjective criteria
in which various attributes are assigned a series of ratings (in
the range [0, 10]). The attributes are summed and a diagnosis
is given on the basis of this (e.g. using the Paediatric Crohn’s
Disease Activity Index [19]). A MLP was the best performing
classifier for this stage.
Fig. 2. Conditional multiple classifier system topology.
VI. RESULTS
A. Relevance of novel feature set
The novel feature set of predicted gene functions was the
most relevant type of feature across all three stages of the
hybrid classifier (see Table I). To date no other metage-
nomic classifiers of host health status have used predicted
metagenomes as a feature. However, classification of microbial
communities with predicted metagenomes has occurred with
good results [20]. The Boruta algorithm is an all-relevant
feature selection algorithm that has found widespread use
in metagenomics [5], [6]. Boruta considers a feature to be
relevant if it is better for classification than a copy of the
feature with a different order of values (dubbed shadows).
Irrelevant features are iteratively pruned from the dataset until
none are left. This is in contrast to traditional minimal-optimal
feature selection methods, which seeks to find the smallest
subset of features while optimising classifier performance. The
authors of Boruta argue that minimal-optimal feature selection
can lead to difficulty in detecting overfitting. The aim of
Boruta is to understand the mechanisms of action that created
the dataset.
Classification of disease state with a predicted metagenome
has not been done to date. Adding the novel feature set tripled
the number of features used from the original analysis of a
bacterial census [3]. The novel feature set could cause the
models to overfit on irrelevant features. Determining what
features are relevant and if the relevant features are involved
in mechanisms associated with IBD is an important step in
validating the use of a predicted metagenome as a feature set
for classification.
Carotenoid biosynthesis was a relevant feature in stages I
and II. Carotenoids are a group of organic pigments synthe-
sised by plants and bacteria, and are the pigments that produce
attractive colours in plants. They are sourced mainly from fruit
and vegetables and are antioxidants. The pathogenesis of IBD
is thought to involve oxidative stress. In IBD patients antiox-
idants that circulate in blood plasma - including carotenoids -
are present at significantly lower concentrations than controls
[21]. This pattern is also found in this analysis but in this work
the carotenoid biosynthesis is only measured from bacteria
(plants do not have 16S rRNA). The intestinal microbiome
synthesises a variety of important vitamins that are required
by host metabolism such as vitamin B12. However, limited
work has been done in assessing the role of the microbiota in
carotenoid biosynthesis (e.g. vitamin A). Carotenoid synthesis
by commensal bacteria could contribute to overall host health
in previously undiscovered ways, and imbalances in the intesti-
nal microbiome reduce the amount of carotenoid biosynthesis
occurring.
Genes associated with bacterial infections were found to
be relevant features in IBD subjects. There is evidence that
conserved genes associated with Vibrio cholerae can be ac-
quired by Campylobacter concisus, leading to the pathogenesis
of IBD. Vibrio cholerae can increase the permeability of
the intestine, triggering the onset and relapse of IBD. Vibrio
TABLE I
DISTRIBUTION OF RELEVANT FEATURES PER STAGE. FEATURE
RELEVANCE CALCULATED WITH THE BORUTA ALGORITHM [17].
CLINICAL HISTORY INCLUDES SUBJECT PRESCRIPTION HISTORY (E.G.
RECENT ANTIBIOTIC USE).
Stage Who’s there?Bacterial abundance
What are they doing?
Gene functions Clinical
IBD presence 27% 64% 9%
IBD subtype 34% 53% 13%
IBD activity 20% 80% 0%
TABLE II
CROSS VALIDATED AVERAGE PRECISION SCORE PER STAGE.
Stage Average precision score Support (classes balanced)
IBD presence 0.71 111
IBD subtype 0.65 111
IBD activity 0.61 45
cholerae genes are associated with the first stage of the hybrid
classifier, which determines if IBD is present in its active form
or remission [22].
B. Hybrid classifier performance
The first stage of the hybrid classifier showed good clas-
sification performance for the IBD remission class (see Fig-
ure 3a). The IBD active and control classes showed excellent
performance. The second stage of the hybrid classifier had
excellent performance for the failsafe control class and good
performance for the Crohn’s disease and ulcerative colitis (see
Figure 3b). The third stage of the hybrid classifier had good
performance for all classes (see Figure 3c).
Despite roughly tripling the amount of features when com-
pared with the original analysis of a bacterial census (643
features were used including a bacterial census, predicted
gene abundances, and clinical features in the final model) the
SVMs used in the first two stages performed well. SVMs are
insensitive to high feature-to-sample ratios. Random forests
and SVMs performed poorly on the third stage of the hybrid
classifier. Both could consistently identify mild and severe
classes but were unable to classify moderate classes. A MLP
showed good performance for all classes despite the nonlin-
earity of the data.
The average precision score of the last stage of the hybrid
classifier shows the worst performance across all stages. This
could be contributed to the lack of training data (see Table II)
compared with the other two training stages. Additionally,
classification of a subjective criteria (i.e. a class arising from
a rating rather than a biological test) is a difficult problem.
C. Discussion
A method for the detection and stratification of IBD pres-
ence, IBD subtype, and IBD severity from a bacterial census
of the intestinal microbiome, inferred genetic content of the
bacterial population, and patient clinical history via a hybrid
classifier was presented. An analysis of the relevant features
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Stage I with 10-fold cross validation
Mean ROC active (area = 0.89)
Mean ROC healthy (area = 0.90)
Mean ROC remission (area = 0.79)
(a) Stage I: Classification of IBD presence with a support vector
machine. IBD remission classification performance was good, IBD
active and control classification performance was excellent.
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Stage II with 10-fold cross validation
Mean ROC CD (area = 0.70)
Mean ROC NM (area = 0.90)
Mean ROC UC (area = 0.74)
(b) Stage II: Classification of IBD subtype with a support vec-
tor machine. Crohn’s disease and ulcerative colitis classification
performance was good, failsafe control class classification perfor-
mance was excellent.
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Stage III with 5-fold cross validation
Mean ROC mild (area = 0.80)
Mean ROC moderate (area = 0.82)
Mean ROC severe (area = 0.87)
(c) Stage III: Classification of IBD severity with a multilayer
perceptron. All classes showed good to excellent performance.
Fig. 3. Classification performance as measured by Area Under a Receiver
Operating Characteristic Curve (ROC AUC) of the three-stage hybrid classi-
fier. A ROC curve measures the ability of a test to correctly classify subjects
and is a superior method of measuring performance to other metrics such as
accuracy. A ROC AUC of 0.5 is a worthless test (equal to random chance,
shown as the dotted diagonal line).
across all stages of the hybrid classifier showed that predicted
genetic content was a valuable feature type, forming the
majority of relevant features.
The performance of a classifier as measured by a Receiver
Operating Characteristic (ROC) analysis is often measured
via the area under the curve (AUC). The ROC AUC is
often a better indicator of classifier performance than the
misclassification rate or a loss matrix [23]. In [3] the sensitivity
and specificity of the random forest classifier matched or
surpassed alternative clinical methods (i.e. non-colonoscopy
tests) for detecting IBD. The hybrid classifier presented in this
work shows superior performance to the standalone random
forest classifier.
An advantage of using a conditional multiple classifier
system is its ability to maintain good performance for three dif-
ferent classification problems across nine classes. A MLP was
the only algorithm capable of reliably classifying all classes
for stage III, while SVMs showed superior performance for
stages I and II. The three stages were designed to provide
relevant information to a clinician which could guide treatment
minimising the need for invasive colonoscopy. SVMs have
been rarely used for metagenomic classification problems but
show good performance in this case. Very little work has
been done in applying MLPs to metagenomic classification
problems. MLPs have shown value here for the classification
of disease properties determined by subjective criteria. This is
commonly done in many diseases with uncertain aetiologies,
including depression.
The Boruta algorithm validated the use of predicted
metagenomes as a novel feature set for the classification of
IBD from marker gene surveys. Boruta revealed relevant fea-
tures involved in biological mechanisms behind the pathogen-
esis of IBD. Significantly reduced abundance of antioxidant
carotenoids in IBD subjects has been previously measured
from blood plasma but not from the intestinal microbiome
[21]. Carotenoids are typically sourced from fresh fruit and
vegetables, as they provide plants with bright pigments. The
role of the intestinal microbiome providing the human host
with nutrients and vitamins has been well documented. No
work to date has described the role of the intestinal micro-
biome in providing carotenoids to the host.
Genes associated with the lifecycle of pathogenic bacteria
were also detected as relevant by the Boruta algorithm. Of note
is the Vibrio cholerae lifecycle which is relevant for the first
stage of the hybrid classifier that identifies IBD in remission,
active IBD, and control classes. Evidence has been found that a
combination of Vibrio cholerae and Campylobacter concisus is
implicated in altering the permeability of the intestine, leading
to IBD relapse into an active state [22]. This was previously
missed by the bacterial census. Identifying bacterial species
with a 16S marker gene survey is difficult due to technical
limitations of the protocol. Species that are identified are
typically present in very low abundances. This creates highly
sparse feature vectors. Sparse data is challenging to learn from
because it can increase the hypothesis space through which the
learning algorithm must search.
VII. CONCLUSION AND FUTURE WORK
In this work we present a novel combination of SVMs
and MLPs in a conditional multiple classifier system that can
discriminate the presence, subtype, and activity of paediatric
IBD from a stool sample - avoiding the need for invasive
colonoscopy - is presented in this work. SVMs and MLPs
are rarely applied in metagenomic classification, but both
have shown good performance. Work to date in associating
human microbiomes with host health status has focused on
analysing the bacterial groups present in the gut. Analysing
what is occurring in a microbiome has required shotgun
sequencing, which can be cost prohibitive for dozens or hun-
dreds of metagenomic samples. The novel use of a predicted
metagenome as a feature set, produced from a 16S marker
gene survey with PiCRUSt, was validated with the Boruta
algorithm. Metagenomic functions are a promising source of
features for the classification of disease in a host. Features
identified as relevant by Boruta have been independently
implicated in the pathogenesis of IBD and IBD relapse. In
each stage of the hybrid classifier the predicted metagenomes
formed the majority of relevant features.
Future work will include validating the predicted
metagenome in an independent cohort with metagenomic
shotgun sequencing, including analysis of host genotype.
Diseases with uncertain and complex aetiologies often have a
genetic component. Discriminating between Crohn’s disease
and ulcerative colitis (stage II) was the most difficult stage for
the hybrid classifier with the poorest performance. Ulcerative
colitis only affects the intestine, while Crohn’s disease affects
the entire gastrointestinal tract - host genetic factors contribute
to this difference. Fusing parallelised classifier decisions at
each stage would further improve system performance and
reduce uncertainty.
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